Platelet hypoaggregability in hereditary hypertriglyceridemic rats: relation to plasma triglycerides
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
9526957
DOI
10.1016/s0049-3848(97)00264-8
PII: S0049-3848(97)00264-8
Knihovny.cz E-resources
- MeSH
- Adenosine Diphosphate pharmacology MeSH
- Platelet Aggregation drug effects genetics physiology MeSH
- Bridged Bicyclo Compounds, Heterocyclic MeSH
- Hydrazines pharmacology MeSH
- Hypertension blood complications genetics MeSH
- Hypertriglyceridemia blood complications genetics MeSH
- Kinetics MeSH
- Rats MeSH
- Fatty Acids, Unsaturated MeSH
- Rats, Inbred Lew MeSH
- Receptors, Thromboxane antagonists & inhibitors MeSH
- Triglycerides blood MeSH
- Thrombin pharmacology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Adenosine Diphosphate MeSH
- Bridged Bicyclo Compounds, Heterocyclic MeSH
- Hydrazines MeSH
- Fatty Acids, Unsaturated MeSH
- Receptors, Thromboxane MeSH
- SQ 29548 MeSH Browser
- Triglycerides MeSH
- Thrombin MeSH
To define better the relationships between lipid metabolism disturbances and platelet aggregation we have examined these parameters in hereditary hypertriglyceridemic and control Lewis rats. Hereditary hypertriglyceridemic rats are hypertensive and have high plasma triglycerides but not elevated plasma total cholesterol. In the present study, we have demonstrated that platelets from hereditary hypertriglyceridemic rats have lowered initial rate and maximal aggregation after stimulation with thrombin or ADP in comparison with controls. These two strains did not differ significantly in the inhibition of platelet aggregation by the thromboxane A2 receptor inhibitor, SQ 29 548. In hereditary hypertriglyceridemic rats, the thrombin response, as well as the contribution of the thromboxane A2-sensitive pathway, were positively associated with the plasma level of triglycerides. Similar trend was found in Lewis rats. However, the slopes of these relationships were reduced in hereditary hypertriglyceridemic rats. These alterations of the aggregatory responses in hereditary hypertriglyceridemic rats were independent of blood pressure and plasma cholesterol level. In conclusion, our results showed a clear-cut platelet hypoaggregability to both thrombin and ADP in hypertensive hypertriglyceridemic rats. This hypoaggregability was not due to an impaired function of the thromboxane A2 pathway but could be connected with disturbances of lipid metabolism.
References provided by Crossref.org
Research on Experimental Hypertension in Prague (1966-2009)